SamChunDang Pharm Co. Ltd. | Mutual Funds
Mutual Funds that own SamChunDang Pharm Co. Ltd.
DFA Emerging Markets Small Cap Series
128,414
0.57%
0
0.07%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
121,557
0.55%
-4,357
0.02%
04/30/2018
Mirae Asset TIGER Health Care ETF
26,697
0.12%
7,062
0.74%
04/30/2018
22,907
0.1%
287
0.38%
09/06/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
17,427
0.08%
0
0.01%
09/05/2018
DFA TA World (ex-US) Core Equity Portfolio
8,172
0.04%
0
0.01%
04/30/2018
iShares III Plc - MSCI Emerging Markets Small Cap
8,123
0.04%
0
0.08%
09/05/2018
SPDR S&P International Small Cap ETF
6,383
0.03%
0
0.03%
09/06/2018
iShares MSCI Emerging Markets Small Cap ETF
5,564
0.03%
0
0.09%
09/05/2018
DFA World (ex-US) Core Equity Portfolio
5,368
0.02%
0
0.01%
04/30/2018
| Address |
71 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.scd.co.kr |
| Updated |
09/14/2018 |
| Sam Chun Dang Pharm Co., Ltd. engages in the manufacture of pharmaceuticals. Its products include antibiotics, cures for circulatory and respiratory system, medicines for digestive system and ophtalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea. |
